1. Home
  2. CDRE vs TXG Comparison

CDRE vs TXG Comparison

Compare CDRE & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cadre Holdings Inc.

CDRE

Cadre Holdings Inc.

HOLD

Current Price

$42.80

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$17.77

Market Cap

1.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDRE
TXG
Founded
2012
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.6B
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
CDRE
TXG
Price
$42.80
$17.77
Analyst Decision
Buy
Buy
Analyst Count
2
13
Target Price
$34.50
$14.73
AVG Volume (30 Days)
289.5K
3.3M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
0.89%
N/A
EPS Growth
33.82
N/A
EPS
1.11
N/A
Revenue
$619,068,000.00
$641,814,000.00
Revenue This Year
$12.51
$4.50
Revenue Next Year
$8.21
N/A
P/E Ratio
$38.67
N/A
Revenue Growth
19.94
1.92
52 Week Low
$27.07
$6.78
52 Week High
$46.64
$20.34

Technical Indicators

Market Signals
Indicator
CDRE
TXG
Relative Strength Index (RSI) 53.75 57.17
Support Level $41.56 $17.06
Resistance Level $44.08 $19.29
Average True Range (ATR) 1.35 1.08
MACD 0.03 -0.10
Stochastic Oscillator 71.60 48.84

Price Performance

Historical Comparison
CDRE
TXG

About CDRE Cadre Holdings Inc.

Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The Company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: